Prevalence of Cerebral Large Vessel Occlusion Among Acute Ischemic Stroke Patients in Assiut University Hospitals

NCT ID: NCT07326410

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-02-01

Study Completion Date

2027-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prevalence of Large Vessel Occlusion among acute ischemic stroke patients in Assiut University hospitals

1. Study Objectives

Primary Objective:

\- To determine the prevalence of LVO among acute ischemic stroke (AIS) patients presenting to Assiut University hospitals

Secondary Objectives:
* To describe clinical and radiological characteristics of LVO patients.
* To assess factors associated with LVO (age, sex, stroke severity, comorbidities).
2. Study Design

* Type: single center, prospective observational cross-sectional study
* Duration: 12-month recruitment period
* Setting: Assiut university hospitals, stroke unit.
3. Study Population

Inclusion Criteria:

* Adults (≥18 years)
* Diagnosed with acute ischemic stroke within 24 hours of symptom onset
* Underwent vascular imaging (CTA or MRA) on admission

Exclusion Criteria:

* Hemorrhagic stroke
* Stroke mimics
* Incomplete imaging data 4. Definitions

Large Vessel Occlusion (LVO) defined as occlusion in:

* Intracranial ICA
* M1 or proximal M2 segments of MCA
* Basilar artery ± Optional: A1 6. Data Collection

Clinical Data:

* Demographics (age, sex)
* Risk factors (HTN, DM, AF, CAD, smoking)
* NIHSS on admission and discharge mRS on admission and discharge
* Onset-to-door time
* Imaging modality used

Imaging Data:

* Site of occlusion
* ASPECTS (optional)
* Collateral status (optional if available)

Hospital Data:

* Facility type (public vs private)
* Door-to-CT and door-to-CTA times 8. Analysis Plan
* Primary: Prevalence of LVO = Number of LVO cases / Total AIS patients with vascular imaging
* Subgroup analysis: By age group, sex, region, NIHSS
* Secondary: Logistic regression to identify predictors of LVO

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prevalence of Large Vessel Occlusion among acute ischemic stroke patients in Assiut University hospitals

1. Study Objectives

Primary Objective:

\- To determine the prevalence of LVO among acute ischemic stroke (AIS) patients presenting to Assiut University hospitals

Secondary Objectives:
* To describe clinical and radiological characteristics of LVO patients.
* To assess factors associated with LVO (age, sex, stroke severity, comorbidities).
2. Study Design

* Type: single center, prospective observational cross-sectional study
* Duration: 12-month recruitment period
* Setting: Assiut university hospitals, stroke unit.
3. Study Population

Inclusion Criteria:

* Adults (≥18 years)
* Diagnosed with acute ischemic stroke within 24 hours of symptom onset
* Underwent vascular imaging (CTA or MRA) on admission

Exclusion Criteria:

* Hemorrhagic stroke
* Stroke mimics
* Incomplete imaging data 4. Definitions

Large Vessel Occlusion (LVO) defined as occlusion in:

* Intracranial ICA
* M1 or proximal M2 segments of MCA
* Basilar artery ± Optional: A1 6. Data Collection

Clinical Data:

* Demographics (age, sex)
* Risk factors (HTN, DM, AF, CAD, smoking)
* NIHSS on admission and discharge mRS on admission and discharge
* Onset-to-door time
* Imaging modality used

Imaging Data:

* Site of occlusion
* ASPECTS (optional)
* Collateral status (optional if available)

Hospital Data:

* Facility type (public vs private)
* Door-to-CT and door-to-CTA times 8. Analysis Plan
* Primary: Prevalence of LVO = Number of LVO cases / Total AIS patients with vascular imaging
* Subgroup analysis: By age group, sex, region, NIHSS
* Secondary: Logistic regression to identify predictors of LVO

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults (≥18 years)
* Diagnosed with acute ischemic stroke within 24 hours of symptom onset
* Underwent vascular imaging (CTA or MRA) on admission

Exclusion Criteria

* Hemorrhagic stroke
* Stroke mimics
* Incomplete imaging data
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmad Tarek Aly Sayed

Resident of neurology

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed Nasr Professor of neurology, Professor

Role: CONTACT

+201009949677

Related Links

Access external resources that provide additional context or updates about the study.

https://pubmed.ncbi.nlm.nih.gov/30415226/

Prevalence of cerebral Large Vessel Occlusion among acute ischemic stroke

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Prevalence of Cerebral LVO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.